Page 65 - 2019_10 resto del Mondo_web

IL-4 contributes to thrombocytopenia in AML
native haematopoiesis. Nature. 2018;553
(7687):212-216.
22. Yamamoto R, Morita Y, Ooehara J, et al.
Clonal analysis unveils self-renewing line- age-restricted progenitors generated directly from hematopoietic stem cells. Cell. 2013;154(5):1112-1126.
23. Madisen L, Zwingman TA, Sunkin SM, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13(1):133- 140.
24. Wright DE, Cheshier SH, Wagers AJ, Randall TD, Christensen JL, Weissman IL. Cyclophosphamide/granulocyte colony- stimulating factor causes selective mobiliza- tion of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood. 2001;97(8):2278-2285.
25. Cheng H, Liang PH, Cheng T. Mouse hematopoietic stem cell transplantation. Methods Mol Biol. 2013;976:25-35.
26. Houlihan DD, Mabuchi Y, Morikawa S, et al. Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-alpha. Nat Protoc. 2012;7(12):2103- 2111.
27. Kawamoto T. Use of a new adhesive film for the preparation of multi-purpose fresh- frozen sections from hard tissues, whole- animals, insects and plants. Arch Histol Cytol. 2003;66(2):123-143.
28. Heazlewood SY, Neaves RJ, Williams B, Haylock DN, Adams TE, Nilsson SK. Megakaryocytes co-localise with hemopoi- etic stem cells and release cytokines that up- regulate stem cell proliferation. Stem Cell Res. 2013;11(2):782-792.
29. Sun J, Ramos A, Chapman B, et al. Clonal dynamics of native haematopoiesis. Nature. 2014;514(7522):322-327.
30. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand dis- ease: defects in hemostasis and thrombosis. Proc Nati Acad Sci U S A. 1998;95(16):9524- 9529.
31. Sanjuan-Pla A, Macaulay IC, Jensen CT, et
al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierar- chy. Nature. 2013;502(7470):232-236.
32. Deutsch VR, Tomer A. Megakaryocyte development and platelet production. Br J Haematol. 2006;134(5):453-466.
33. Trakala M, Partida D, Salazar-Roa M, et al. Activation of the endomitotic spindle assembly checkpoint and thrombocytope- nia in Plk1-deficient mice. Blood. 2015;126 (14):1707-1714.
34. Ryu KH, Chun S, Carbonierre S, et al. Apoptosis and megakaryocytic differentia- tion during ex vivo expansion of human cord blood CD34+ cells using thrombopoi- etin. Br J Haematol. 2001;113(2):470-478.
35. De BS, Sabri S, Daugas E, et al. Platelet for- mation is the consequence of caspase activa- tion within megakaryocytes. Blood. 2002;100(4):1310.
36. Pitchford SC, Lodie T, Rankin SM. VEGFR1 stimulates a CXCR4-dependent transloca- tion of megakaryocytes to the vascular niche, enhancing platelet production in mice. Blood. 2012;120(14):2787-2795.
37. Sonoda Y, Kuzuyama Y, Tanaka S, et al. Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture. Blood. 1993;81(3):624-630.
38. Talaat RM, Elmaghraby AM, Barakat SS, El- Shahat M. Alterations in immune cell sub- sets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin Exp Immunol. 2014;176 (2):291-300.
39. Elshal M, Takahashi Y, Chakrabarti S, et al. Complex alterations in serum cytokines and increased Il-4 levels characterize patients developing chronic thrombocytopenia after allogeneic hematopoietic cell transplanta- tion. Blood. 2004;104(11):4985-4985.
40. Takeda K, Tanaka T, Shi W, et al. Essential role of Stat6 in IL-4 signalling. Nature. 1996;380(6575):627-630.
41. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271-282.
42. Woytschak J, Keller N, Krieg C, et al. Type 2 interleukin-4 receptor signaling in neu- trophils antagonizes their expansion and migration during infection and inflamma- tion. Immunity. 2016;45(1):172-184.
43. Dohner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommenda- tions from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453-474.
44. Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med. 1994;331(14):896-903.
45. Capitano M, Zhao L, Cooper S, et al. Phosphatidylinositol transfer proteins regu- late megakaryocyte TGF-beta1 secretion and hematopoiesis in mice. Blood. 2018;132(10):1027-1038.
46. Shivdasani RA, Rosenblatt MF, Zucker- Franklin D, et al. Transcription factor NF-E2 is required for platelet formation independ- ent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 1995;81(5):695-704.
47. Catani L, Amabile M, Luatti S, et al. Interleukin-4 downregulates nuclear factor- erythroid 2 (NF-E2) expression in primary megakaryocytes and in megakaryoblastic cell lines. Stem Cells. 2001;19(4):339-347.
48. Pinho S, Marchand T, Yang E, Wei Q, Nerlov C, Frenette PS. Lineage-biased hematopoiet- ic stem cells are regulated by distinct niches. Dev Cell. 2018;44(5):634-641.e634.
49. Löwenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027- 1036.
50. Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOL- TA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-con- trolled trials. Lancet Respir Med. 2016;4(10): 781-796.
haematologica | 2019; 104(10)
1961